A New Method for the Label-Free Detection of Vascular Endothelial Growth Factor Based on DNAzymes

2016 ◽  
Vol 69 (1) ◽  
pp. 85
Author(s):  
Zhuwu Lv ◽  
Ke Wang ◽  
Xiaolu Zhang

The possibility of performing reliable cancer diagnosis even before any symptoms of disease appears is crucial for increasing therapeutic treatment success and patient survival rates. Herein, an ultrasensitive colorimetric sandwich sensor for vascular endothelial growth factor (VEGF) detection is introduced. The peroxidase-like DNAzyme catalyzes the oxidation of 2,2′-azino-bis(3-ethylbenzothiazoline)-6-sulfonic acid, which generates a blue–green colorimetric signal. This method can detect VEGF at a concentration as low as 10 nM. This strategy will be a promising tool for bioanalytical and clinical applications.

2019 ◽  
Vol 29 (7) ◽  
pp. 893-897
Author(s):  
Hannes Sallmon ◽  
Tünay Aydin ◽  
Stefanie Hort ◽  
Anja Kubinski ◽  
Christina Bode ◽  
...  

AbstractBackground:Vascular endothelial growth factor is critically involved in ductus arteriosus closure. Polymorphisms in the vascular endothelial growth factor gene have been associated with several diseases in neonates and adults.Aim:Herein, we investigated if vascular endothelial growth factor polymorphism rs2010963 status is associated with patent ductus arteriosus incidence and/or pharmacological treatment success.Methods:We assessed rs2010963 status in 814 preterm infants (<1500 g birth weight) by means of restriction fragment length polymorphism analysis. DNA samples were obtained from dry-spot cards used for the German national newborn screening program. Clinical data were obtained by retrospective chart review.Results:We could not find any statistically significant difference in the incidence of patent ductus arteriosus depending on vascular endothelial growth factor rs2010963 polymorphism status. Furthermore, no statistically significant associations between vascular endothelial growth factor polymorphism rs2010963 status and cyclooxygenase inhibitor treatment success were observed.Conclusion:Our results indicate that there is no association between vascular endothelial growth factor polymorphism rs2010963 status and the occurrence of patent ductus arteriosus or the response to cyclooxygenase inhibitor treatment in a large cohort of preterm infants. Additional studies are needed to determine the role of genetic factors on patent ductus arteriosus incidence and treatment response.


1999 ◽  
Vol 74 (2) ◽  
pp. 235-240 ◽  
Author(s):  
Chi-An Chen ◽  
Wen-Fang Cheng ◽  
Chien-Nan Lee ◽  
Tzer-Ming Chen ◽  
Cheng-Che S. Kung ◽  
...  

The Analyst ◽  
2017 ◽  
Vol 142 (13) ◽  
pp. 2419-2425 ◽  
Author(s):  
Huige Zhang ◽  
Liang Peng ◽  
Maoxing Li ◽  
Ji Ma ◽  
Shengda Qi ◽  
...  

Sensitive detection of a low abundant protein is essential for biomedical research and clinical diagnostics.


Sign in / Sign up

Export Citation Format

Share Document